← All Co-diagnostics, INC filings

Co-diagnostics, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
CODX
Co-diagnostics, INC
10-K: Co-Diagnostics Reports Annual Results, Withdraws FDA Submission for At-Home COVID-19 Test
Co-Diagnostics, Inc. files its annual report on Form 10-K, detailing financial results for 2024 and announcing the withdrawal of its FDA 510(k) submission for its at-home COVID-19 PCR test.
NASDAQ
CODX
Co-diagnostics, INC
10-K: Co-Diagnostics, Inc. Outlines Capital Structure and Regulatory Strategy in Annual 10-K Filing
Co-Diagnostics, Inc.'s annual 10-K filing details its capital structure, ongoing development of its PCR platform, and regulatory submissions, while also acknowledging a significant revenue decline due to reduced COVID-19 test sales.